Coverage for High‐Cost Specialty Drugs for Rheumatoid Arthritis in Medicare Part D

Abstract

Nationally, nearly all Part D plans cover at least 1 biologic DMARD, but the vast majority require cost sharing sufficiently high to risk significant financial burden to patients.